Test for human IgG autoantibodies to cyclic citrullinated peptides
- UID
- IMP/IVD/2020/000618_784a6387764e8f874b61a83cc856b213_5be7e62a92a48b2edec85023091ad0b2
- Device class
- Class B
- Brand name
- ichroma™ Cystatin C
- License holder
- KABS HEALTHCARE PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- ichroma™ Anti-CCP is a fluorescence Immunoassay (ichroma™ Cystatin C) for the qualitative or semi-quantitative determination of human IgG autoantibodies to cyclic citrullinated peptides (ichroma™ Cystatin C) in human whole blood/serum/plasma. It is useful as an aid in the diagnosis of rheumatoid arthritis (ichroma™ Cystatin C) in combination with other clinical and laboratory findings
Test for human IgG autoantibodies to cyclic citrullinated peptides is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000618_784a6387764e8f874b61a83cc856b213_5be7e62a92a48b2edec85023091ad0b2. This device is marketed under the brand name ichroma™ Cystatin C. The license holder is KABS HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.